Asiaticoside Mitigates Alzheimer’s Disease Pathology by Attenuating Inflammation and Enhancing Synaptic Function
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241511976 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sai Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Triterpenes, Synapses, Inflammation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nature Science Foundation of Jiangsu Province, Postdoctoral Excellence Program of Jiangsu Province.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder, hallmarked by the accumulation of amyloid-β (Aβ) plaques and neurofibrillary tangles. Due to the uncertainty of the pathogenesis of AD, strategies aimed at suppressing neuroinflammation and fostering synaptic repair are eagerly sought. Asiaticoside (AS), a natural triterpenoid derivative derived from Centella asiatica, is known for its anti-inflammatory, antioxidant, and wound-healing properties; however, its neuroprotective function in AD remains unclear. Our current study reveals that AS, when administered (40 mg/kg) in vivo, can mitigate cognitive dysfunction and attenuate neuroinflammation by inhibiting the activation of microglia and proinflammatory factors in Aβ1-42-induced AD mice. Further mechanistic investigation suggests that AS may ameliorate cognitive impairment by inhibiting the activation of the p38 MAPK pathway and promoting synaptic repair. Our findings propose that AS could be a promising candidate for AD treatment, offering neuroinflammation inhibition and enhancement of synaptic function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
- Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.
- Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
- State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
- School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK.
ORCID-Profile: Zheying Zhu
Förderung
- Nature Science Foundation of Jiangsu Province
- Postdoctoral Excellence Program of Jiangsu Province
Zitieren
APA
Liu, S., Chen, L., Li, J., Sun, Y., Xu, Y., Li, Z., Zhu, Z., & Li, X. (2023). Asiaticoside Mitigates Alzheimer’s Disease Pathology by Attenuating Inflammation and Enhancing Synaptic Function. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241511976
Vancouver
Liu S, Chen L, Li J, Sun Y, Xu Y, Li Z, et al. Asiaticoside Mitigates Alzheimer’s Disease Pathology by Attenuating Inflammation and Enhancing Synaptic Function. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241511976
BibTeX
@article{Liu2023,
author = {Liu, Sai and Chen, Long and Li, Jinran and Sun, Yuan and Xu, Yue and Li, Zhaoxing and Zhu, Zheying and Li, Xinuo},
title = {Asiaticoside Mitigates Alzheimer’s Disease Pathology by Attenuating Inflammation and Enhancing Synaptic Function},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241511976}
}
EUVIMED